CytomX Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CTMX Nasdaq 2836 www.cytomx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CytomX Therapeutics, Inc.

How The CytomX Therapeutics (CTMX) Story Is Shifting With New Colorectal Cancer Data And Risks - May 28th, 2026 7:11 am
CytomX Therapeutics to Present at Upcoming June Investor Conferences - May 21st, 2026 6:00 am
CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs - May 18th, 2026 6:00 am
New Forecasts: Here's What Analysts Think The Future Holds For CytomX Therapeutics, Inc. (NASDAQ:CTMX) - May 13th, 2026 5:19 am
Earnings Beat: CytomX Therapeutics, Inc. (NASDAQ:CTMX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - May 11th, 2026 6:49 am
CytomX (CTMX) Q1 2026 Earnings Transcript - May 8th, 2026 12:04 pm
CytomX Therapeutics Q1 Earnings Call Highlights - May 7th, 2026 6:38 pm
CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates - May 7th, 2026 5:05 pm
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update - May 7th, 2026 2:15 pm
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates - May 6th, 2026 3:25 pm
CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 - Apr 30th, 2026 6:00 am
Small Cap or Megacap: Which Healthcare Stock Is Right for You? - Apr 22nd, 2026 4:48 pm
CytomX Therapeutics, Inc. (CTMX) A Top Healthcare Penny Stock Amid Colorectal Cancer Treatment Progress - Apr 14th, 2026 3:56 am
Analysts Bullish on CytomX Therapeutics (CTMX) As CTMX Prices $250 Million Offering - Apr 12th, 2026 3:50 pm
How The CytomX Therapeutics (CTMX) Story Is Shifting With New Colorectal Cancer Data - Apr 9th, 2026 10:33 pm
CytomX Therapeutics (CTMX) Making Progress on Key Metastatic Colorectal Cancer Treatment - Apr 6th, 2026 3:25 pm
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last? - Apr 1st, 2026 5:56 am
CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress - Mar 27th, 2026 3:51 pm
How The CytomX Therapeutics (CTMX) Narrative Is Shifting With New Colorectal Cancer Data - Mar 26th, 2026 11:07 am
A Look At CytomX Therapeutics (CTMX) Valuation After Positive Varsetatug Masetecan Phase 1 Expansion Results - Mar 20th, 2026 7:04 pm